Life ScienceCompany
InnoSyn Ownership
Who owns InnoSyn?
InnoSyn is owned by Merieux Equity Partners. It was acquired on February 5, 2024.
Is InnoSyn PE-backed?
Yes. InnoSyn is owned by private equity investor Merieux Equity Partners.
InnoSyn Business Overview
Where is InnoSyn headquartered?
InnoSyn is headquartered in Geleen, Netherlands.
What sector is InnoSyn in?
InnoSyn is a life science company.
Life Science M&A Summary in 2024
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.
Join Mergr to view all 186 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 172 by strategics.